I need help revising my article review.
Critique each article using the appropriate appraisal form.
·
Clinical Practice Guideline
Download Clinical Practice Guideline
Use the information below to help you know which section of the article to use to answer the questions in the template:
· Introduction and its subsections have the purpose or WHY study done.>
· Methodssection and its subsections contains HOW the study was done.
· Results, Discussion and Conclusionssection have WHAT was found.
APPENDIX A
Appraisal Guide:
Recommendations of a Clinical Practice Guideline
Citation:
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
Synopsis
What group or groups produced the guideline?
What does the guideline address? Clinical questions, conditions, interventions?
What population of patients does the guideline address?
Did the panel use existing SRs or did it conduct its own?
What clinical outcomes was the guideline designed to achieve?
What are the main recommendations?
What system was used to grade the recommendations?
Credibility
Was the panel made up of people with the necessary expertise? Yes No Not clear
Are the goals for developing the guideline explicit and clear? Yes No Not clear
*Does the guideline production process include all the widely
recognized steps? Yes No Not clear
*Were the SRs used of high quality? Yes No Not clear
Are differences in evidence for subpopulations recognized? Yes No Not clear
*Is the evidence supporting each
recommendation graded or stated as adequate to strong? Yes No Not clear
Is the guideline current? (based on
issue date and date of most recent evidence included) Yes No Not clear
Are the recommendations credible? Yes All Yes Some No
Clinical Significance
Are essential elements of any
recommended action or intervention clearly stated? Yes No Not clear
*Is the magnitude of benefit associated
with each recommendation clinically important? Yes No Not clear
*Is the panel’s certainty or confidence
in each recommendation clear? Yes No Not clear
Were patient concerns, values, and risks addressed? Yes No Not clear
Were downsides or costs of each recommendation addressed? Yes No Not clear
Was the guideline reviewed by
outside experts and a member of
the public or field tested? Yes No Not clear
Are the recommendations
clinically significant? Yes All Yes Some No
Applicability
Does the guideline address a problem,
weakness, or decision we are examining in our setting? Yes No
Did the research evidence involve
patients similar to ours, and was the
setting similar to ours? Yes No Some
What changes, additions, training, or
purchases would be needed to
implement and sustain a clinical
protocol based on these conclusions? Specify.
____________________________________________________________________________
__________________________________________________
Vocal Music Therapy for Chronic Pain:
A Mixed Methods Feasibility Study
Ming Yuan Low, MA, MT-BC,1 Clarissa Lacson, MA, MT-BC,1 Fengqing Zhang, PhD,2
Amy Kesslick, MA, MT-BC, LPC,3 and Joke Bradt, PhD, MT-BC1
Abstract
Objective: The purpose of this study was to determine the feasibility and preliminary effects of a vocal music
therapy (VMT) program on chronic pain management.
Design: A mixed methods intervention design was used in which qualitative data were embedded within a
randomized controlled trial.
Setting: An urban nurse-management health center on the East Coast of the United States.
Subjects: Participants (N = 43) were predominantly Black (79%) and female (76.7%) with an average pain
duration of 10 years.
Intervention: Participants were randomly allocated to a 12-week VMT program or a waitlist control.
Outcome measures: We tracked consent rate (percentage of participants enrolled out of total number
screened), attrition rate, and treatment adherence. We used PROMIS
�
(Patient Reported Outcomes Measure-
ment Information System) tools to measure pain interference, pain-related self-efficacy, pain intensity, de-
pression, anxiety, positive effect, and well-being, ability to participate in social activities, and satisfaction with
social roles at baseline and week 12. VMT participants also completed the Patient Global Impression of Change
Scale. We conducted semistructured interviews to better understand participants’ experience of the intervention.
Results: The consent rate was 56%. The attrition rate was 23%. Large treatment effects (partial eta squared) were
obtained for self-efficacy (0.20), depression (0.26), and ability to participate in social activities (0.24). Medium effects
were found for pain intensity (0.10), anxiety (0.06), positive effect, and well-being (0.06), and small effects for pain
interference (0.03) and satisfaction with social roles (0.03). On average, participants felt moderately better after
completion of the VMT program (M = 4.93, standard deviation = 1.98). Qualitative findings suggest that VMT resulted
in better self-management of pain, enhanced psychological well-being, and stronger social and spiritual connections.
Conclusions: Recruitment into the 12-week program was challenging, but quantitative and qualitative
findings suggest significant benefits of VMT for chronic pain management.
Keywords: music therapy, pain management, clinical trials
Introduction
Chronic pain is a significant public health problemamounting to an annual health care expense of ap-
proximately half a trillion dollars in the United States
alone.
1
In 2016, the Centers for Disease Control and
Prevention issued recommendations to move away from
opioids and instead use nonpharmacological thera-
pies for the treatment of chronic pain.
2
The use of music
for the
Take free quizzes online at acsjournals.com/ce
ONLINE CONTINUING EDUCATION ACTIVITY
After reading the article “Clinical Practice Guidelines on the Evidence-Based Use of Integrative Therapies During and After Breast Cancer Treatment,” the learner
should be able to:
ARTICLE TITLE: Clinical Practice Guidelines on the Evidence-Based Use of Integrative Therapies During
and After Breast Cancer Treatment
CONTINUING MEDICAL EDUCATION ACCREDITATION AND DESIGNATION STATEMENT:
Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME)
for physicians.
Blackwell Futura Media Services designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credit™. Physicians should only claim credit
commensurate with the extent of their participation in the activity.
CONTINUING NURSING EDUCATION ACCREDITATION AND DESIGNATION STATEMENT:
The American Cancer Society (ACS) is accredited as a provider of continuing nursing education (CNE) by the American Nurses Credentialing Center’s Commission on
Accreditation.
Accredited status does not imply endorsement by the ACS or the American Nurses Credentialing Center of any commercial products displayed or discussed in
conjunction with an educational activity. The ACS gratefully acknowledges the sponsorship provided by Wiley for hosting these CNE activities.
EDUCATIONAL OBJECTIVES:
ACTIVITY DISCLOSURES:
No commercial support has been accepted related to the development or publication of this activity.
ACS CONTINUING PROFESSIONAL EDUCATION COMMITTEE DISCLOSURES:
Editor: Ted Gansler, MD, MBA, MPH, has no financial relationships or interests to disclose.
Associate Editor: Durado Brooks, MD, MPH, has no financial relationships or interests to disclose.
Lead Nurse Planner: Cathy Meade, PhD, RN, FAAN, has no financial relationships or interests to disclose.
Editorial Advisory Member: Richard C. Wender, MD, has no financial relationships or interests to disclose.
NURSING ADVISORY BOARD DISCLOSURES:
Maureen Berg, RN, has no financial relationships or interests to disclose.
Susan Jackson, RN, MPH, has no financial relationships or interests to disclose.
Barbara L
World Journal of
Meta-Analysis
World J Meta-Anal 2019 November 28; 7(9): 406-435
ISSN 2308-3840 (online)
Published by Baishideng Publishing Group Inc
W J M A
World Journal of
Meta-Analysis
Contents Irregular Volume 7 Number 9 November 28, 2019
REVIEW
406 Treatment of early stage (T1) esophageal adenocarcinoma: Personalizing the best therapy choice
Kumble LD, Silver E, Oh A, Abrams JA, Sonett JR, Hur C
MINIREVIEWS
418 Mechanisms of action of aqueous extract from the Hunteria umbellata seed and metformin in diabetes
Ejelonu OC
423 Fecal microbiota transplantation: Historical review and current perspective
Leung PC, Cheng KF
META-ANALYSIS
428 Use of music during colonoscopy: An updated meta-analysis of randomized controlled trials
Heath RD, Parsa N, Matteson-Kome ML, Buescher V, Samiullah S, Nguyen DL, Tahan V, Ghouri YA, Puli SR, Bechtold ML
WJMA https://www.wjgnet.com November 28, 2019 Volume 7 Issue 9I
Contents
World Journal of Meta-Analysis
Volume 7 Number 9 November 28, 2019
ABOUT COVER Editorial Board Member of World Journal of Meta-Analysis, Xiangchun Shen,
PhD, Director, Postdoc, Professor, Teacher, School of Pharmaceutical
Sciences, State Key Laboratory of Functions and Applications of Medicinal
Plants, Guizhou Medical University, Guian New District 550025, Guizhou
Province, China
AIMS AND SCOPE The primary aim of World Journal of Meta-Analysis (WJMA, World J Meta-
Anal) is to provide scholars and readers from various fields of clinical
medicine with a platform to publish high-quality meta-analysis and
systematic review articles and communicate their research findings online.
WJMA mainly publishes articles reporting research results and findings
obtained through meta-analysis and systematic review in a wide range of
areas, including medicine, pharmacy, preventive medicine, stomatology,
nursing, medical imaging, and laboratory medicine.
INDEXING/ABSTRACTING The WJMA is now abstracted and indexed in China National Knowledge
Infrastructure (CNKI), China Science and Technology Journal Database (CSTJ), and
Superstar Journals Database
RESPONSIBLE EDITORS FOR
THIS ISSUE
Responsible Electronic Editor: Yan-Xia Xing
Proofing Production Department Director: Yun-Xiaojian Wu
NAME OF JOURNAL
World Journal of Meta-Analysis
ISSN
ISSN 2308-3840 (online)
LAUNCH DATE
May 26, 2013
FREQUENCY
Irregular
EDITORS-IN-CHIEF
Giuseppe Biondi-Zoccai
EDITORIAL BOARD MEMBERS
https://www.wjgnet.com/2308-3840/editorialboard.htm
EDITORIAL OFFICE
Jin-Lei Wang, Director
PUBLICATION DATE
November 28, 2019
COPYRIGHT
© 2019 Baish